Home LiteratureArticle Details
PMID: 8609232 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome.

The Journal of clinical investigation ·Vol. 97 ·No. 3 ·1996-02-01 ·Pages 755-60

Kumagai M, Manabe A, Pui CH, Behm FG, Raimondi SC, Hancock ML, Mahmoud H, Crist WM, Campana D

Abstract

We developed a stroma cell culture system that suppresses apoptosis of malignant cells from cases of B-lineage acute lymphoblastic leukemia. By multiparameter flow cytometric measurements of cell recovery after culture on stromal layers, we assessed the growth potential of 70 cases of newly diagnosed B-lineage acute lymphoblastic leukemia and related the findings of treatment outcome in a single program of chemotherapy. The numbers of leukemic cells recovered after 7 d of culture ranged from < 1 to 292% (median, 91%). The basis of poor cell recoveries from stromal layers appeared to be a propensity of the lymphoblasts to undergo apoptosis. The probability of event-free survival at 4 yr of follow-up was 50 +/- 9% (SE) among patients with higher cell recoveries ( > 91%), and 94 +/- 6% among those with reduced cell recoveries (+/- 91%; P = 0.0003). The prognostic value of leukemic cell recovery after culture exceeded estimates for all other recognized high-risk features and remained the most significant after adjustment with all competing covariates. Thus, the survival ability of leukemic cells on bone marrow-derived stromal layers reflects aggressiveness of the disease and is a powerful, independent predictor of treatment outcome in children with B-lineage acute lymphoblastic leukemia.

MeSH Terms
Analysis of Variance Antineoplastic Combined Chemotherapy Protocols Apoptosis B-Lymphocytes/cytology Burkitt Lymphoma/therapy Cell Survival Child Culture Techniques/methods Hematopoietic Stem Cells/cytology Humans Treatment Outcome
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Kumagai M
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, USA.
Manabe A
Pui C H
Behm F G
Raimondi S C
Hancock M L
Mahmoud H
Crist W M
Campana D
References (26)
26 references, click to expand
  1. Biology and treatment of acute lymphoblastic leukemia.
    J Pediatr. 1994 Apr;124(4):491-503 PMID: 8151461
  2. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia.
    Blood. 1994 Apr 1;83(7):1731-7 PMID: 8142640
  3. PITSLRE protein kinase activity is associated with apoptosis.
    Mol Cell Biol. 1995 Jan;15(1):1-11 PMID: 7528324
  4. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
    Blood. 1995 Feb 15;85(4):873-8 PMID: 7849309
  5. Ligation of CD38 suppresses human B lymphopoiesis.
    J Exp Med. 1995 Mar 1;181(3):1101-10 PMID: 7869031
  6. Childhood leukemias.
    N Engl J Med. 1995 Jun 15;332(24):1618-30 PMID: 7753142
  7. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
    Br J Cancer. 1977 Jan;35(1):1-39 PMID: 831755
  8. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis.
    Br Med J. 1978 Dec 2;2(6151):1529-30 PMID: 281981
  9. Cell death: the significance of apoptosis.
    Int Rev Cytol. 1980;68:251-306 PMID: 7014501
  10. Genetic instability in the development of drug resistance.
    Semin Oncol. 1985 Sep;12(3):222-30 PMID: 4048965
  11. Phenotypic and karyotypic properties of hyperdiploid acute lymphoblastic leukaemia of childhood.
    Br J Haematol. 1985 Sep;61(1):113-23 PMID: 3863665
  12. Differentiation-linked leukemogenesis in lymphocytes.
    Science. 1986 Nov 7;234(4777):697-704 PMID: 3535067
  13. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
    N Engl J Med. 1989 Oct 19;321(16):1080-5 PMID: 2552313
  14. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia.
    Blood. 1990 Oct 15;76(8):1449-63 PMID: 2207320
  15. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy.
    Lancet. 1991 Jan 12;337(8733):61-6 PMID: 1670723
  16. Why does childhood acute lymphoblastic leukemia with hyperdiploidy show a favorable prognosis?
    Cancer Genet Cytogenet. 1990 Dec;50(2):273-5 PMID: 2265406
  17. Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia.
    Semin Hematol. 1991 Jul;28(3 Suppl 4):15-21 PMID: 1780747
  18. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
    J Clin Oncol. 1992 Apr;10(4):606-13 PMID: 1548523
  19. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia.
    Blood. 1992 May 1;79(9):2370-7 PMID: 1373973
  20. Bcl-2 initiates a new category of oncogenes: regulators of cell death.
    Blood. 1992 Aug 15;80(4):879-86 PMID: 1498330
  21. Features of apoptotic cells measured by flow cytometry.
    Cytometry. 1992;13(8):795-808 PMID: 1333943
  22. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.
    Leukemia. 1993 Mar;7(3):482-8 PMID: 7680404
  23. A case of acute megakaryocytic leukemia with hematogones.
    Leukemia. 1993 Nov;7(11):1900-3 PMID: 8231260
  24. The molecular basis of leukemia.
    N Engl J Med. 1994 Feb 3;330(5):328-36 PMID: 8277954
  25. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells.
    Blood. 1994 Feb 1;83(3):758-66 PMID: 7507732
  26. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
    Leukemia. 1994 Jul;8(7):1116-23 PMID: 7913512
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1996-02-01
Pages
755-60
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC507113
Subset
IM
Grants
NCI NIH HHS · CA20180 · United States
NCI NIH HHS · P30-CA21765 · United States
NCI NIH HHS · R01-CA58297 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]